Journal of Lipid Research · 2000 · 158 citations · 56 references
Life SciencesNeurologyNeuroscienceDementiaLipid BiochemistryNeurodegenerationAlzheimer DiseaseCerebrospinal Fluid BiomarkersDementia BiomarkersLipid MetabolismLipoprotein AnalysisLipoprotein MetabolismAcyltransferase EnzymesApolipoprotein A-i MetabolismApolipoprotein FunctionApolipoprotein MetabolismCerebrospinal Fluid SystemControlsLecithin-cholesterol Acyltransferase DeficiencyLipid Transfer Proteins
We investigated the lipoprotein distribution and composition in cerebrospinal fluid (CSF) in a group of patients with Alzheimer's disease (AD) or affected by other types of dementia in comparison to non-demented controls. We found slightly decreased apolipoprotein (apo)E and cholesterol concentrations in CSF of AD patients and moderately increased apoA-I concentrations, while in patients suffering from other types of dementia the apoA-I CSF concentration was increased. ApoA-IV concentrations varied widely in human CSF, but were not associated with any clinical condition. HDL(2)-like apoE-containing lipoproteins represent the major lipoprotein fraction. In CSF of normal controls, only a minor HDL(3)-like apoA-I-containing lipoprotein fraction was observed; this fraction was more prevalent in AD patients. ApoA-II was recovered mostly in the HDL(3) density range, while apoA-IV was not associated with lipoproteins but appeared in a lipid-free form, co-localizing with LCAT immunoreactivity. Bi-dimensional analysis demonstrated pre-beta and alpha apoA-I-containing particles; apoE and apoA-II were detected only in alpha-migrating particles. ApoA-IV distributed both to pre-beta and gamma-migrating particles; the LCAT signal was co-localized in this gamma-migrating fraction. Enzymatically active LCAT was present in human CSF as well as PLTP activity and mass; no CETP mass was detected. In CSF from AD patients, LCAT activity was 50% lower than in CSF from normal controls. CSF lipoproteins induced a significant cholesterol efflux from cultured rat astrocytes, suggesting that they play an active role in maintaining the cholesterol homeostasis in brain cells.
56
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Robert E. Pitas, J K Boyles, S H Lee et al. · Journal of Biological Chemistry · 1987 · 710 citations · Full text
Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein
Tuomo Polvikoski, Raimo Sulkava, Matti Haltia et al. · New England Journal of Medicine · 1995 · 492 citations
Life Sciences, Genetics, Neurology +17